# SoftBank Vision Fund's Biotech Investments: 12 Startups in Its Portfolio (2026)

> The 12 Biotech startups SoftBank Vision Fund has backed, by stage: $2.2B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/softbank-investment-advisers-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Series C and later

5

- [Relay Therapeutics](https://millionrounds.com/company/relay-therapeutics)
- [Pear Therapeutics](https://millionrounds.com/company/pear-therapeutics)
- [Dewpoint Therapeutics](https://millionrounds.com/company/dewpoint-therapeutics)
- [Vividion Therapeutics](https://millionrounds.com/company/vividion-therapeutics)
- [Plexium](https://millionrounds.com/company/plexium)

## Stage not reported

4

- [Vir Biotechnology](https://millionrounds.com/company/vir-biotechnology)
- [Alto Pharmacy](https://millionrounds.com/company/alto-pharmacy)
- [LUMICKS](https://millionrounds.com/company/lumicks)
- [Neumora Therapeutics](https://millionrounds.com/company/neumora-therapeutics)

## Series B

3

- [Repertoire Immune Medicines](https://millionrounds.com/company/repertoire-immune-medicines)
- [Variant Bio](https://millionrounds.com/company/variant-bio)
- [Hexagon Bio](https://millionrounds.com/company/hexagon-bio)

## Segment by segment

### Series C and later

5 startups · $1.6B raised

- [**Relay Therapeutics**](https://millionrounds.com/company/relay-therapeutics) Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion. United States $932M
- [**Pear Therapeutics**](https://millionrounds.com/company/pear-therapeutics) Pear Therapeutics is a Massachusetts-based prescription digital therapeutic platform that offers solutions such as clinical engage United States $239M
- [**Dewpoint Therapeutics**](https://millionrounds.com/company/dewpoint-therapeutics) Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. United States $196M
- [**Vividion Therapeutics**](https://millionrounds.com/company/vividion-therapeutics) We are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with d United States $185M
- [**Plexium**](https://millionrounds.com/company/plexium) Plexium is a biotechnology company based in San Diego, California, founded in 2018. United States $88M

### Stage not reported

4 startups · $225M raised

- [**Vir Biotechnology**](https://millionrounds.com/company/vir-biotechnology) Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions. United States $150M
- [**Alto Pharmacy**](https://millionrounds.com/company/alto-pharmacy) Alto is a digital pharmacy that makes the prescription experience easier. United States $50M
- [**LUMICKS**](https://millionrounds.com/company/lumicks) LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy. Netherlands $22M
- [**Neumora Therapeutics**](https://millionrounds.com/company/neumora-therapeutics) Neumora Therapeutics operates as a clinical-stage biotechnology company. United States $2.6M

### Series B

3 startups · $371M raised

- [**Repertoire Immune Medicines**](https://millionrounds.com/company/repertoire-immune-medicines) Repertoire Immune Medicines is a clinical stage biotechnology company. - $189M
- [**Variant Bio**](https://millionrounds.com/company/variant-bio) Variant Bio is a biotechnology company based in Seattle, founded in 2018. United States $105M
- [**Hexagon Bio**](https://millionrounds.com/company/hexagon-bio) Hexagon Bio is a biopharmaceutical company based in Menlo Park, California, founded in 2016. United States $77M

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names SoftBank Vision Fund as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Sector portfolio **SoftBank Vision Fund's AI portfolio** 35 startups · $12B](https://millionrounds.com/portfolio-maps/softbank-investment-advisers-ai-portfolio)[Sector portfolio **SoftBank Vision Fund's Fintech portfolio** 10 startups · $4.5B](https://millionrounds.com/portfolio-maps/softbank-investment-advisers-fintech-portfolio)[Co-investors **Who invests with SoftBank Vision Fund** 110 co-investors](https://millionrounds.com/portfolio-maps/softbank-investment-advisers-co-investors)[Portfolio map **SoftBank Vision Fund portfolio map** 104 startups · $50B](https://millionrounds.com/portfolio-maps/softbank-investment-advisers-portfolio-map)[Investments abroad **SoftBank Vision Fund's investments in the United States** 60 startups · $34B](https://millionrounds.com/portfolio-maps/softbank-investment-advisers-investments-united-states)[Sector portfolio **Antler's AI portfolio** 168 startups · $3.8B](https://millionrounds.com/portfolio-maps/antler-ai-portfolio)

## Raising from investors like SoftBank Vision Fund?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)
